The software slowdown that kept me out of the stock just reversed. Is an unchanged revenue forecast reason to wait longer?

Defining Tesla (TSLA-3.08%) has always been a challenging question for investors. As an electric-vehicle maker, Tesla has ...

Take IonQ ( IONQ -3.47%) and D-Wave ( QBTS -3.88%), for example. Their share prices are down 29% and 54% year to date, ...

Architectural specifications and the adoption of electronic locks create multiyear revenue visibility that pricing discipline ...

As the chart shows, Rigetti's sales multiple is more than six times IonQ's, suggesting the latter is the better value. This, ...

Cancellations now stem from clinical failures rather than funding shortages, signaling a healthier market for contract ...

Production ramps create near-term cost pressure, but management sees a clear path to 18% operating margins by decade's end.

Net revenue reached $1.5 billion, up 14% year over year. Cloud-based solutions accounted for 85% of fintech software bookings. Year-to-date enterprise Verafin client signings reached 12 financial ...

Management is using government tariff refunds -- money returned on import taxes -- to lower prices on 50 essential items that rural customers buy regularly. This targeted value strategy is ...

Pricing power and operational discipline held margins steady even as sales flatlined, signaling resilience beyond the current ...

Niew stated, "Wait, we are at a point where we are pretty close to capacity constraint," noting that sequential growth in the Precision Devices segment will likely remain flat through Q1 2027 as a ...

Two of these creatures are Pfizer ( PFE +1.91%) and AbbVie ( ABBV +0.14%). But in an environment of rising interest rates, ...